Publication Beamlines Strategic Pillar
Stobbs, Jarvis A.; Ghazani, Saeed M.; Tu, Kaiyang; Pensini, Erica; Fameau, Anne-Laure et al. (2025). Dimyristoylphosphoethanolamine Addition During Chocolate Manufacture Promotes Proper Tempering under Simple Cooling Conditions without Shear. Crystal Growth and Design 25(12) , 4621-4635. 10.1021/acs.cgd.5c00575. BMIT-BM, BXDS-WLE, EIML, MID-IR Agriculture
Stobbs, Jarvis A. (2025). Multiscale Analysis Framework for Chocolate Tempering using Phospholipids. Supervisor: Marangoni, Alejandro G.. Ontario, Canada: University of Guelph. https://hdl.handle.net/10214/29011. BMIT-BM, BXDS-WLE, MID-IR Agriculture
Stobbs, Jarvis A.; Ghazani, Saeed M.; Donnelly, Mary-Ellen; Marangoni, Alejandro G. (2025). Chocolate Tempering: A Perspective. Crystal Growth and Design . 10.1021/acs.cgd.5c00269. BMIT-BM, BXDS-WLE Agriculture
Koekuyt, Henry A. (2025). Functional and Solid-State Changes in Lipid-Complexed Legume Starches: Plant-Based Protein Side-Stream Functionalization. Supervisor: Marangoni, Alejandro G.. Guelph, Ontario, Canada: University of Guelph. https://hdl.handle.net/10214/28841. BXDS-WLE Agriculture
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C 8 H 14 N 2 (SO 4 ). Powder Diffraction , 1-5. 10.1017/s0885715625000545. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C 27 H 30 N 2 O 2 . Powder Diffraction , 1-6. 10.1017/s0885715625100869. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C 19 H 21 N 4 O)(C 7 H 7 O 3 S)(H 2 O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C 24 H 28 N 3 O 4 Cl(H 2 O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C 24 H 32 O 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100729. BXDS-WLE Health
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C 14 H 19 NO 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100791. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. BXDS-WLE Health